Cloud DX (TSXV:CDX.H) Research & Development: C$0.17 Mil (TTM As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:CDX.H Cloud DX Inc TSXV:CDX.H
31 GF Score
Price C$0.13
View Full Analysis

What is Cloud DX Research & Development?

Cloud DX TSXV:CDX.H 31 Research & Development is C$0.17 Mil as of Sep. 2024. GuruFocus rates TSXV:CDX.H with a GF Score™ of 31/100.

Research & Development is the aggregate amount of research and development expenses during the year. Cloud DX's Research & Development for the three months ended in Sep. 2024 was C$0.01 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.17 Mil.

Cloud DX  (TSXV:CDX.H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cloud DX Research & Development Related Terms

Cloud DX Research & Development Historical Data

* Premium members only.

The historical data trend for Cloud DX's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cloud DX Research & Development Chart

Cloud DX Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
0.00 0.55 0.47 0.40 0.19

Cloud DX Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.11 0.03 0.03 0.01
TSXV:CDX.H
31GF Score
Cloud DX Inc TSXV:CDX.H
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cloud DX Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.17 Mil mean?
Cloud DX (TSXV:CDX.H) has a Research & Development of C$0.17 Mil as of Sep. 2024. Research and development expense is the total cost for research and development activities. View historical data on Cloud DX and its competitors.
Is Cloud DX's Research & Development too high?
Cloud DX's current Research & Development is C$0.17 Mil. Overall, Cloud DX has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Cloud DX's Research & Development compare to GEHC and VEEV?
Cloud DX's Research & Development of C$0.17 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cloud DX and its competitors. Cloud DX's current Research & Development is C$0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cloud DX stock overvalued right now?
Cloud DX (TSXV:CDX.H) has a current Research & Development of C$0.17 Mil. The current Research & Development is C$0.17 Mil. Cloud DX's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cloud DX (TSXV:CDX.H), the current Research & Development is C$0.17 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cloud DX Business Description

Address 72 Victoria Street South, Kitchener, ON, CAN, N2G 4Y9
Cloud DX Inc provides a digital and virtual healthcare platform called Cloud DX Connected Health. It is used by private hospitals, public hospitals, and healthcare organizations across North America to provide patient remote monitoring, enable aging in place, and deliver hospital-quality post-surgical care. The platform helps to reduce the need for hospitalization and manage the costs of healthcare delivery through more efficient use of resources. Geographically, the company generates a majority of its revenue from Canada and the rest from the United States.
31GF Score

Get the complete analysis for TSXV:CDX.H

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.13
Price